Aug. 26 (UPI) --The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for people with Type 2 diabetes. In 2022, the FDA signed off on the system for ...

In this 13-week, multicenter trial, adults with insulin-treated type 2 diabetes were randomly assigned in a 2:1 ratio to receive AID or to continue their pretrial insulin-delivery method (control ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. State-level out-of-pocket insulin caps did not boost ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with type 2 diabetes using an automated insulin ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation automated insulin delivery ...

If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 ...

The FDA cleared the first automated insulin dosing device for adults with type 2 diabetes, the agency announced on Monday. An interoperable automated glycemic controller, Insulet's SmartAdjust ...

Could a one-hour procedure that involves zapping a part of the intestines mean no more insulin for millions of folks with Type 2 diabetes? Maybe, according to a small study scheduled for presentation ...

Diabetes affects 37 million people in the U.S. The Centers for Disease Control and Prevention estimates another 96 million people – or 1 in 3 adults – have prediabetes, a condition where blood sugar ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase its expanding focus on Dexcom CGM ...